SynCore Biotechnology Receives Investigational New D...
2017-07-20
Investigational New Drug (IND) clearance from TFDA represents a key milestone in SynCore’s new drug pipeline development program. The global ... more

SynCore Biotechnology to Exhibit at the 2017 Bio Tai...
2017-06-29
Taipei, Taiwan, June 27th, 2017 - SynCore Biotechnology Co., Ltd (SynCore) (4192: phaseTT) announced today that the company will exhibit at the upcoming 2017... more

SynCore Bio to present the Phase I study of SB01 at ...
2017-05-18
SynCore Biotechnology Co., Ltd. (SynCore) is selected to present the Phase I study of SB01 at the 2017 American Society of Clinical Oncology (ASCO) Annual Me... more

SynCore Biotechnology Receives Investigational New D...
2017-04-18
• Investigational New Drug (IND) clearance from US FDA represents a key milestone in SynCore’s new drug pipeline development program • Th... more

SynCore Bio is selected to present the Phase I study...
2017-04-04
SynCore Bio is selected to present the Phase I study data of new anti-cancer molecule SB01 at ASCO 2017  SynCore Biotechnology Co., Ltd. (SynCore) r... more